Medixa Pharma SRL
Medixa Pharma reported total assets of €1.46m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026).
The score of Medixa Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +54 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medixa Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 22 Jul 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 24 Aug 2022
Medixa Pharma's financial analysis
- Solvency33.8%sector median: 49.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medixa Pharma
Medixa Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0849.178.283
- VAT number
- BE0849178283
- Peppol
- Registered · 0208:0849178283 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Oct 2012
- Registered office
- 4990 Lierneux
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Medixa Pharma (SRL) has been based in Lierneux since 2012, active in: business and other management consultancy activities. For 2025, it reports a net profit of 54,457 € and equity of 492,598 €; its revenue is not published. Its solvency stands at 33.8%, below the median of its sector (49.1%).
Companies similar to Medixa Pharma
Companies in the same business, of comparable size and area, outside its group.
- Swakopmund Business and other management consultancy activities Lasne · balance sheet €1.46m
- Five Financial Solutions Business and other management consultancy activities Mechelen · balance sheet €1.46m
- Phenicia Business and other management consultancy activities Antwerp · balance sheet €1.46m
- Artekom Business and other management consultancy activities Izegem · balance sheet €1.45m
- LOVI Invest Business and other management consultancy activities Wingene · balance sheet €1.45m
- BOD & Bara Consult Business and other management consultancy activities Waimes · balance sheet €1.46m
- D.U.B. Business and other management consultancy activities Schaerbeek · balance sheet €1.46m
- TEM Consulting Business and other management consultancy activities Tournai · balance sheet €1.46m
Frequently asked questions about Medixa Pharma
What is the revenue of Medixa Pharma?
Medixa Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medixa Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0849178283 for Medixa Pharma, if the company is VAT-registered. Its company number (CBE) is 0849.178.283.
Where is the registered office of Medixa Pharma?
According to the CBE register, the registered office of Medixa Pharma is in 4990 Lierneux.
What is the equity of Medixa Pharma?
At the close of the 2025 financial year, the equity of Medixa Pharma amounts to 492,598 €, a solvency of 33.8% of total assets.
Who manages Medixa Pharma?
The register lists 1 active mandates at Medixa Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medixa Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →